It’s been a cool week for stem cell and other associated kinds of research. In this post I have a series of links to a variety of interesting developments and papers. Gene therapy cures bubble boy infants. William Wan over at the WaPo on this good news. Nope, this wasn’t done with CRISPR, but rather […]
There’s nothing like stem cell good news and interesting publications to perk one up on a Monday. Enjoy. What recent papers have struck you as exciting? Novel stem cell-based cancer approaches (Part 1) It was exciting when Fate Therapeutics got the first induced pluripotent stem cell (IPSC) IND in the U.S. for their IPSC-derived natural killer cell
Stem cell good news: novel cancer work, new CA bills, Alzheimer’s, & more pubs Read More »
I keep a yearly hub of stem cell & regenerative medicine meetings here on The Niche. Below I’ve pasted the list for 2019, which continues to grow. If you don’t see yours listed, send me an email with the info including a link (knoepflerATucdavisDOTedu). These meeting listings are not endorsements and I try to make
Stem cell & regenerative medicine meetings for you to go to in 2019 Read More »
For a long time at the end of each year, I’ve been making stem cell predictions for the coming year. Most often I’ve been making a “top 20” list of predictions and today’s post has my list for 2019. You can see how I did for 2018 here, which might have been my best year
20 stem cell & regenerative medicine predictions for 2019 Read More »
Each year I make a list of stem cell predictions for the following year and I’ll release my predictions for 2019 soon, but first I’m grading how my 20 predictions for 2018 turned out. It seems I did better than usual predicting what would happen this year. I only got a couple partial credit or
Good final grades on my 20 x 2018 stem cell predictions Read More »
The FDA has issued a recall of the main stem cell product of a California firm called Liveyon that is linked to unproven stem cell clinics. The recall seems to have been due to “adverse reactions.” An emerging big player in the birth-related stem cell clinic area? I’ve been hearing the name Liveyon pop up
FDA recalls Liveyon stem cell product: blow to big clinic supplier? Read More »
Here is my initial list of 2019 Stem Cell Meetings & Conferences. Send me your listings if you don’t see your meeting here so I can start fleshing out the list more. Meeting listings are not endorsements and I try to make this list fairly comprehensive of as many stem cell meetings as I can.
A germinal list of 2019 stem cell meetings and conferences Read More »
Here is our listing of 2019 Stem Cell Meetings & Conferences. Send me your listings if you don’t see your meeting here. Meeting listings are not endorsements and I try to make this list fairly comprehensive. January ARM Cell & Gene Therapies State of the Industry Briefing San Francisco, CA, USA (Held January 7, 2019)
2019 Stem Cell Meetings List Read More »
We heard this week about the encouraging news of a new CRISPR-stem cell collaboration between stem cell biotech ViaCyte and CRISPR Therapeutics. The goal of the team is to make genetically engineered pancreatic derivatives from stem cells that would have a unique immune stealthiness. If such an approach was successful, patients would not need to
Quick Q&A with ViaCyte CEO on CRISPR-stem cell work Read More »
Stem cell news is always burbling up, sometimes right there in front of us on the web and other times via networks of people. Astellas news. Some may remember there used to be this pioneering stem cell biotech called ACT, which then became Ocata, and finally was acquired by the big company Astellas. One of
Stem cell news bites: Astellas trial, cystic fibrosis claim, a few cool papers Read More »